Synthetic Peptide Vaccine Market Revenue 2024 to 2034
Synthetic Peptide Vaccine Market Revenue 2024 to 2034
The Synthetic Peptide Vaccine Market is projected to expand from USD 19.19 Bn in 2024 to USD 79.97 Bn by 2034, at a CAGR of 15.3%. Growth is fueled by rising demand for targeted immunization, advances in peptide synthesis technologies, and increasing applications in cancer, infectious diseases, and chronic conditions.
Report ID: 10355
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD 19.19 Bn
Forecast Year,
USD 79.97 Bn
CAGR, 2025 -
15.34%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Synthetic Peptide Vaccine Market Size Analysis
Synthetic Peptide Vaccine Market Size By Therapy & Class 2024 to 2034 (USD )
| Therapy & Class | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Small Molecules | 6.14 | 7.04 | 8.16 | 9.42 | 10.87 | 12.58 | 14.49 | 16.69 | 19.19 | 22.22 | 25.63 |
| Biologics | 6.52 | 7.55 | 8.70 | 10.08 | 11.61 | 13.36 | 15.47 | 17.90 | 20.61 | 23.82 | 27.51 |
| Advanced Therapies | 3.45 | 4.02 | 4.63 | 5.32 | 6.15 | 7.07 | 8.18 | 9.42 | 10.96 | 12.56 | 14.53 |
| Others | 3.07 | 3.52 | 4.03 | 4.63 | 5.34 | 6.16 | 7.05 | 8.10 | 9.35 | 10.73 | 12.30 |
Synthetic Peptide Vaccine Market Size By Indication 2024 to 2034 (USD )
| Indication | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oncology | 6.91 | 8.00 | 9.21 | 10.63 | 12.28 | 14.15 | 16.38 | 18.90 | 21.83 | 25.10 | 29.01 |
| Cardio-Metabolic | 3.45 | 3.96 | 4.59 | 5.27 | 6.03 | 6.96 | 8.03 | 9.28 | 10.77 | 12.46 | 14.33 |
| Infectious | 3.07 | 3.55 | 4.09 | 4.74 | 5.47 | 6.29 | 7.22 | 8.29 | 9.53 | 10.96 | 12.64 |
| CNS | 2.69 | 3.07 | 3.53 | 4.06 | 4.68 | 5.40 | 6.22 | 7.17 | 8.25 | 9.56 | 11.02 |
| Others | 3.07 | 3.55 | 4.11 | 4.74 | 5.50 | 6.38 | 7.33 | 8.47 | 9.73 | 11.25 | 12.98 |
Synthetic Peptide Vaccine Market Size By Distribution 2024 to 2034 (USD )
| Distribution | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital Pharmacy | 8.44 | 9.76 | 11.21 | 12.88 | 14.87 | 17.16 | 19.71 | 22.87 | 26.41 | 30.41 | 35.08 |
| Retail Pharmacy | 6.91 | 7.96 | 9.22 | 10.71 | 12.33 | 14.19 | 16.41 | 18.86 | 21.70 | 25.08 | 28.89 |
| Online/Other | 3.84 | 4.41 | 5.10 | 5.85 | 6.77 | 7.83 | 9.07 | 10.38 | 12.00 | 13.84 | 16.00 |
Synthetic Peptide Vaccine Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 7.68 | 8.90 | 10.27 | 11.89 | 13.63 | 15.66 | 18.05 | 20.81 | 23.95 | 27.67 | 32.05 |
| Europe | 5.37 | 6.17 | 7.14 | 8.23 | 9.54 | 10.94 | 12.64 | 14.55 | 16.78 | 19.34 | 22.21 |
| Asia Pacific | 4.61 | 5.30 | 6.08 | 6.98 | 8.09 | 9.44 | 10.89 | 12.63 | 14.64 | 16.83 | 19.42 |
| Latin America | 0.77 | 0.88 | 1.02 | 1.18 | 1.35 | 1.57 | 1.81 | 2.07 | 2.35 | 2.73 | 3.14 |
| Middle East & Africa | 0.77 | 0.88 | 1.02 | 1.17 | 1.36 | 1.57 | 1.79 | 2.07 | 2.38 | 2.75 | 3.15 |
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
